LASEROPTEK Co Ltd announces that its PicoLO picosecond Nd:YAG laser recently received US Food and Drug Administration 510(k) clearance for use in dermatology and general and plastic surgery.
PicoLO generates high peak power and consistent picosecond pulse duration producing strong photomechanical forces within the skin to quickly and effectively break down and fragment pigments such as those found in tattoos. In addition, PicoLO incorporates LASEROPTEK’s patented Diffractive Optical Element (DOE) fractional technology consistently creating Laser-induced Optical Breakdown (LIOB) in the dermis even at low power.
This combination of photomechanical effect and LIOB gives PicoLO a significant point of difference with picosecond lasers on the market and delivers numerous advantages to both patients and providers, according to a company news release.
“Exceptionally stable energy output and picosecond pulse duration are key technological developments integrated into PicoLO further distancing it from the competition. High stability in both laser output and pulse duration is central to delivering consistently efficacious treatment outcomes while simultaneously minimizing patient discomfort,” says C.J. Lee, CEO of LASEROPTEK, in the release.
[Source(s): LASEROPTEK Co Ltd, PR Newswire]